AlphaVest Acquisition p(ATMV)
Search documents
Morning Market Movers: ATMV, NEUP, BOF, RYOJ See Big Swings
RTTNews· 2025-10-21 11:45
Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - AlphaVest Acquisition Corp (ATMV) is up 71% at $14.24 [3] - BranchOut Food Inc. (BOF) is up 44% at $3.04 [3] - rYojbaba Co., Ltd. (RYOJ) is up 35% at $5.14 [3] - GSI Technology, Inc. (GSIT) is up 25% at $16.24 [3] - Jowell Global Ltd. (JWEL) is up 18% at $2.02 [3] - General Motors Company (GM) is up 9% at $63.68 [3] - Crown Holdings, Inc. (CCK) is up 8% at $103.00 [3] - Spero Therapeutics, Inc. (SPRO) is up 8% at $2.49 [3] - Sunrun Inc. (RUN) is up 6% at $21.90 [3] - Foxx Development Holdings Inc. (FOXX) is up 5% at $4.50 [3] Premarket Losers - Neuphoria Therapeutics Inc. (NEUP) is down 66% at $5.19 [4] - New Era Energy & Digital, Inc. (NUAI) is down 9% at $5.09 [4] - Odyssey Marine Exploration, Inc. (OMEX) is down 8% at $3.28 [4] - Carbon Revolution Public Limited Company (CREV) is down 7% at $4.86 [4] - Coeur Mining, Inc. (CDE) is down 7% at $20.38 [4] - Hecla Mining Company (HL) is down 6% at $13.50 [4] - Verrica Pharmaceuticals Inc. (VRCA) is down 6% at $4.12 [4] - Sensei Biotherapeutics, Inc. (SNSE) is down 5% at $10.06 [4] - Whitehawk Therapeutics, Inc. (WHWK) is down 5% at $2.52 [4] - Greenidge Generation Holdings Inc. (GREE) is down 5% at $2.07 [4]
Morning Market Movers: RYOJ, LGCB, MIRA, FOSL See Big Swings
RTTNews· 2025-10-16 12:11
Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - rYojbaba Co., Ltd. (RYOJ) increased by 134% to $5.09 - Linkage Global Inc (LGCB) rose by 101% to $3.33 - MIRA Pharmaceuticals, Inc. (MIRA) gained 87% to $2.46 - Auddia Inc. (AUUD) went up by 23% to $2.54 - SOPHiA GENETICS SA (SOPH) increased by 16% to $4.99 - J.B. Hunt Transport Services, Inc. (JBHT) rose by 13% to $157.44 - AlphaVest Acquisition Corp (ATMV) increased by 11% to $13.09 - New Era Energy & Digital, Inc. (NUAI) went up by 10% to $3.71 - Critical Metals Corp. (CRML) rose by 9% to $24.80 - Blaize Holdings, Inc. (BZAI) increased by 9% to $6.90 [3] Premarket Losers - Fossil Group, Inc. (FOSL) decreased by 40% to $2.23 - Pinnacle Food Group Limited (PFAI) fell by 25% to $3.41 - American Battery Technology Company (ABAT) declined by 22% to $6.91 - Sadot Group Inc. (SDOT) dropped by 20% to $6.15 - TechCreate Group Ltd. (TCGL) decreased by 14% to $4.14 - PMGC Holdings Inc. (ELAB) fell by 13% to $6.43 - Arcadia Biosciences, Inc. (RKDA) decreased by 13% to $4.73 - ATIF Holdings Limited (ZBAI) dropped by 11% to $9.28 - Roma Green Finance Limited (ROMA) fell by 7% to $2.62 - Australian Oilseeds Holdings Limited (COOT) decreased by 6% to $2.46 [4]
Morning Market Movers: AGRI, QLGN, FLGC, BOXL See Big Swings
RTTNews· 2025-09-22 11:43
Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - AgriFORCE Growing Systems Ltd. (AGRI) has increased by 263% to $8.73 [3] - Qualigen Therapeutics, Inc. (QLGN) has risen by 212% to $8.87 [3] - Flora Growth Corp. (FLGC) is up 103% at $55.36 [3] - Boxlight Corporation (BOXL) has gained 102% to $3.16 [3] - Platinum Analytics Cayman Limited (PLTS) is up 96% at $14.00 [3] - Metsera, Inc. (MTSR) has increased by 59% to $52.99 [3] - Anywhere Real Estate Inc. (HOUS) is up 51% at $10.72 [3] - Fold Holdings, Inc. (FLD) has risen by 30% to $5.93 [3] - ARB IOT Group Limited (ARBB) is up 28% at $8.02 [3] - MBX Biosciences, Inc. (MBX) has increased by 26% to $12.64 [3] Premarket Losers - AlphaVest Acquisition Corp (ATMV) has decreased by 27% to $15.99 [4] - Helius Medical Technologies, Inc. (HSDT) is down 17% at $20.00 [4] - CEA Industries Inc. (BNC) has fallen by 15% to $8.20 [4] - Simpple Ltd. (SPPL) is down 13% at $5.00 [4] - FatPipe, Inc. (FATN) has decreased by 11% to $7.87 [4] - Tharimmune, Inc. (THAR) is down 11% at $3.20 [4] - Yueda Digital Holding (YDKG) has fallen by 11% to $2.98 [4] - American Battery Technology Company (ABAT) is down 10% at $2.94 [4] - AGM Group Holdings Inc. (AGMH) has decreased by 9% to $9.36 [4] - Antelope Enterprise Holdings Limited (AEHL) is down 5% at $3.38 [4]
Morning Market Movers: AGMH, ATMV, BREA, ASST See Big Swings
RTTNews· 2025-09-19 11:53
Core Viewpoint - Premarket trading is showing notable activity with significant price movements indicating potential investment opportunities before the market opens [1] Premarket Gainers - AGM Group Holdings Inc. (AGMH) increased by 185% to $6.36 [3] - AlphaVest Acquisition Corp (ATMV) rose by 77% to $26.80 [3] - Brera Holdings PLC (BREA) saw a 20% increase to $30.00 [3] - Asset Entities Inc. (ASST) gained 18% to $4.54 [3] - 22nd Century Group, Inc. (XXII) also increased by 18% to $2.08 [3] - Millennium Group International Holdings Limited (MGIH) rose by 16% to $2.84 [3] - Robo.ai Inc. (AIIO) increased by 11% to $2.17 [3] - Butterfly Network, Inc. (BFLY) saw a 10% rise to $2.10 [3] - GrafTech International Ltd. (EAF) increased by 9% to $13.91 [3] - Cardlytics, Inc. (CDLX) rose by 8% to $2.99 [3] Premarket Losers - ECD Automotive Design, Inc. (ECDA) decreased by 14% to $3.70 [4] - Champions Oncology, Inc. (CSBR) fell by 8% to $6.11 [4] - Beam Global (BEEM) saw an 8% decline to $2.79 [4] - Fathom Holdings Inc. (FTHM) decreased by 8% to $2.19 [4] - Ventyx Biosciences, Inc. (VTYX) fell by 7% to $2.20 [4] - SciSparc Ltd. (SPRC) decreased by 6% to $4.35 [4] - Lightwave Logic, Inc. (LWLG) fell by 6% to $3.45 [4] - Jasper Therapeutics, Inc. (JSPR) decreased by 6% to $2.43 [4] - StableX Technologies, Inc. (SBLX) fell by 5% to $5.67 [4] - Galecto, Inc. (GLTO) decreased by 5% to $2.70 [4]
AlphaVest Acquisition Corp Files Supplement to Proxy Materials Clarifying Redemption Procedures Related to its Business Combination and Extraordinary General Meeting
Globenewswire· 2025-09-12 22:47
New York, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- AlphaVest Acquisition Corp (the “Company”) today filed a supplement (the “Proxy Supplement”) to its proxy statement dated September 2, 2025, related to its Extraordinary General Meeting to be held on September 19, 2025 (the “Extension Meeting”), at which shareholders will be able to consider and vote on a proposal to extend the time to complete the business combination (the “Extension”). The Proxy Supplement clarified certain procedures related to share ...
AlphaVest Acquisition p(ATMV) - 2025 Q2 - Quarterly Report
2025-08-14 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number 001-41574 ALPHAVEST ACQUISITION CORP (Exact name of registrant as specified in its charter) Cayman Islands N/A ( ...
AlphaVest Acquisition p(ATMV) - 2025 Q1 - Quarterly Report
2025-05-19 22:05
Financial Performance - As of March 31, 2025, the company reported a net income of $8,697, consisting of interest earned on marketable securities and bank interest income of $187,180, offset by formation and operating costs of $178,483[101]. - For the three months ended March 31, 2024, the company had a net income of $349,241, with bank interest income of $678,480, formation and operating costs of $236,926, and an unrealized loss on investments of $92,316[102]. Capital Raising - The company raised gross proceeds of $60,000,000 from the Initial Public Offering of 6,000,000 Units at $10.00 per Unit, along with an additional $3,900,000 from the sale of 390,000 Private Units[103]. - Following the full exercise of the over-allotment option, the total amount placed in the trust account was $70,380,000, which may be used to complete the initial business combination[105]. Assets and Liabilities - As of March 31, 2025, the company had marketable securities in the trust account amounting to $18,407,880, consisting of U.S. government securities with a maturity of 185 days or less[106]. - The company reported a working capital deficit of $2,089,118 as of March 31, 2025, raising substantial doubt about its ability to continue as a going concern[110]. - The company has no off-balance sheet financing arrangements or long-term liabilities as of March 31, 2025[111]. Business Operations - The company has not generated any operating revenues to date and will not do so until the completion of its initial business combination[99]. - The company expects to incur significant costs related to being a public company and for due diligence expenses in connection with the search for a business combination target[100]. - The company has engaged EBC as an advisor for its business combination, agreeing to pay a service fee of 3.5% of the gross proceeds of the IPO upon consummation of the initial business combination[115].
AlphaVest Acquisition p(ATMV) - 2024 Q4 - Annual Report
2025-04-14 20:15
IPO and Financial Proceeds - The Company generated gross proceeds of $60,000,000 from its Initial Public Offering (IPO) by selling 6,000,000 units at $10.00 per unit[23]. - Following the IPO, approximately $70,380,000 was deposited into a trust account, with $550,000 allocated for fees and expenses, and $650,000 available for working capital[26]. - As of December 21, 2023, approximately $50,608,334.49 remained in the trust account after 2,174,171 Ordinary Shares were redeemed for approximately $23,282,935.83[29]. - The net proceeds from the Initial Public Offering may be used for general corporate purposes, including maintenance or expansion of operations post-transaction[44]. - Approximately $650,000 will be available outside the trust account to fund working capital requirements, with offering expenses estimated at $550,000[108]. - Up to $51,108,600 from the net proceeds of the Initial Public Offering and the sale of Private Placement Units will be available to complete the business combination and pay related fees and expenses[130]. Business Combination Plans - The Company entered into a business combination agreement with Wanshun Technology Industrial Group Limited on August 11, 2023[27]. - The Company has extended the deadline to complete a business combination to December 22, 2024, by depositing $55,000 for each monthly extension[30]. - The Company has the ability to extend the time to consummate a business combination up to nine additional months, totaling 33 months from the IPO closing[41]. - The initial business combination must involve target businesses with an aggregate fair market value of at least 80% of the assets held in the trust account[43]. - The company may complete its initial business combination even if a majority of public shareholders do not support it, as it may not hold a shareholder vote unless required by law[74]. - The company may seek shareholder approval for its initial business combination, and its Initial Shareholders may purchase shares from public shareholders, influencing the vote[90]. Financial Condition and Risks - The company has not generated any revenues to date and is classified as an early-stage and emerging growth company[19]. - As of December 31, 2024, the company had a working capital deficiency of $1,745,636, raising substantial doubt about its ability to continue as a going concern[73]. - If the company fails to complete its initial business combination, it will not generate any operating revenues, impacting its financial viability[72]. - The company may need additional financing for general corporate purposes following the initial business combination, with no limitations on raising funds through equity or debt[45]. - The company may be forced to liquidate if it cannot obtain sufficient funds to operate for at least the next 24 months following the Initial Public Offering[105]. - The per-share redemption amount for public shareholders could be less than $10.20 due to potential claims from creditors[112]. Management and Operational Strategy - The management team aims to focus on private companies in Asia with compelling economics and paths to positive operating cash flow[35]. - The company aims to acquire businesses with strong management teams to enhance operational and investment capabilities[42]. - Target businesses should have significant revenue and earnings growth potential through product development and increased production capacity[42]. - The company seeks to acquire businesses capable of generating strong, stable, and increasing free cash flow, particularly those with predictable revenue streams[42]. - The company may pursue business combinations with affiliated entities if they meet established criteria and are approved by independent directors[168]. Market and Competitive Landscape - The Company has identified the Asian market as a key area for growth, driven by private sector expansion and technological innovation[36]. - The company expects to encounter intense competition from other entities with similar business objectives, including private investors and other blank check companies[102]. - Increased competition among special purpose acquisition companies may lead to a scarcity of attractive targets and higher costs for initial business combinations[81]. - The ability of public shareholders to redeem their shares for cash may deter potential business combination targets, complicating the acquisition process[78]. Regulatory and Legal Considerations - The company is subject to reporting obligations under the Exchange Act, including filing annual, quarterly, and current reports with the SEC[55]. - The company is classified as an "emerging growth company," allowing it to take advantage of certain exemptions from reporting requirements[59]. - The company may face challenges in completing a business combination with non-China-based targets due to regulatory scrutiny and potential foreign investment restrictions[70]. - The company may not be able to enforce legal rights if it acquires a business located outside the United States, affecting its operational control[70]. - Changes in Chinese government policies could significantly impact the company's operations and the value of its Ordinary Shares post-combination[70]. Shareholder Dynamics - Initial Shareholders have agreed to vote their shares in favor of the initial business combination, which could facilitate the approval process[75]. - Initial Shareholders will own 55.2% of issued and outstanding Ordinary Shares after the IPO, potentially influencing shareholder votes[176]. - Initial Shareholders acquired 1,725,000 Founder Shares for $25,000, representing 20% of outstanding shares post-IPO[169]. - The company may issue additional Ordinary Shares or preference shares to complete its initial business combination, potentially diluting existing shareholders' interests[70]. Risks Associated with Acquisitions - The company may not adequately assess all significant risk factors in potential business combinations, leading to possible value reductions for shareholders[122]. - The potential loss of key personnel from the target business post-combination could negatively impact operations and profitability[160]. - The company may pursue acquisitions outside of management's expertise, potentially affecting evaluation and operation[120]. - There are risks associated with the management of the target business after the initial business combination, including potential loss of control[179]. Economic and Market Conditions - Political events and social unrest in countries where the company operates could negatively affect business operations[194]. - Inflationary pressures in Asian economies may lead to government actions that could significantly decrease profitability post-acquisition[205]. - Regulations in Asia limiting foreign investments may restrict the number of potential acquisition candidates[206]. - Corporate governance standards in Asia may be weaker than in the United States, potentially hiding detrimental operational practices[208].
AlphaVest Acquisition p(ATMV) - 2024 Q3 - Quarterly Report
2024-11-19 21:57
Financial Performance - As of September 30, 2024, the company reported a net income of $502,021 for the three months ended, consisting of interest income from marketable securities and bank interest income of $684,601, offset by formation and operating costs of $182,580[108]. - For the nine months ended September 30, 2024, the company had a net income of $1,234,008, with total interest income of $1,893,227, offset by formation and operating costs of $566,903 and an unrealized loss of $92,316[109]. Initial Public Offering - The company completed its Initial Public Offering on December 22, 2022, raising gross proceeds of $60,000,000 from the sale of 6,000,000 Units at $10.00 per Unit[111]. - Following the full exercise of the over-allotment option, the total amount placed in the trust account was $70,380,000, which will be used to complete the initial business combination[113]. Trust Account and Marketable Securities - As of September 30, 2024, the company held marketable securities in the trust account amounting to $53,011,509, including $5,419,445 of interest income[115]. Working Capital and Financial Health - The company reported a working capital deficit of $1,276,719 as of September 30, 2024, with cash on hand of only $7,095[116]. - There is substantial doubt about the company's ability to continue as a going concern within one year after the issuance of the financial statements[119]. Business Operations and Costs - The company has not generated any operating revenues to date and does not expect to do so until after the completion of its initial business combination[107]. - The company has incurred significant costs related to its acquisition plans and expects increased expenses due to being a public company[106]. Advisory and Compliance - The company has engaged EBC as an advisor for its business combination, agreeing to pay a service fee of 3.5% of the gross proceeds of the IPO upon consummation of the initial business combination[132]. - Management does not believe that any recently issued accounting standards would have a material effect on financial statements[134]. - The company is classified as a smaller reporting company and is not required to provide additional market risk disclosures[136].
AlphaVest Acquisition p(ATMV) - 2024 Q2 - Quarterly Report
2024-08-19 20:33
Financial Performance - For the three months ended June 30, 2024, the company reported a net income of $382,746, consisting of $530,143 in interest income, offset by $147,397 in formation and operating costs[85]. - For the six months ended June 30, 2024, the company had a net income of $731,987, with total interest income of $1,208,626 and total costs of $384,323, including an unrealized loss of $92,316[85]. Assets and Securities - As of June 30, 2024, the company held marketable securities in the trust account amounting to $51,996,909, which includes $4,734,845 of interest income[90]. - Following the full exercise of the over-allotment option, the total amount placed in the trust account reached $70,380,000[88]. Working Capital and Cash Position - As of June 30, 2024, the company reported a working capital deficit of $874,140 and cash of $13,793[90]. Business Operations and Revenue - The company has not generated any operating revenues to date and does not expect to do so until after completing its initial business combination[84]. - The company has incurred significant costs related to its acquisition plans and anticipates increased expenses due to being a public company[83]. Going Concern - There is substantial doubt about the company's ability to continue as a going concern within one year after the issuance of the financial statements[93]. Financing Arrangements - The company has no off-balance sheet financing arrangements as of June 30, 2024[95]. Initial Public Offering - The company completed its Initial Public Offering on December 22, 2022, raising gross proceeds of $60,000,000 from the sale of 6,000,000 Units at $10.00 per Unit[86].